Given that the survival and proliferation of microglia and macrophages depend on the CSF1R signaling pathway, several CSF1R inhibitors have been developed as potential therapies for neurological disorders and cancer (Cannarile et al. 2017). This evidence concerns the gene CSF1R and nervous system disorder.